Garenoxacin versus Levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology
Not Applicable
- Conditions
- acute rhinosinusitis
- Registration Number
- JPRN-UMIN000012421
- Lead Sponsor
- Hokuriku otolaryngology practiced expert study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) The patients should be treat with intravenous anitimicobial injection because of severe infectious disease (2) Purulent specimens are test agent- resistant bacteria. (3) The patients have improvements in clinical symptoms with another oral antibacterial agent before this examination. (4) The patients are suspected of recurent or odontogenic sinusitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method